Long indwelling double bore catheter
    41.
    发明公开
    Long indwelling double bore catheter 失效
    Doppelkanalkatheter dasüberlängereZeit imKörperverbleiben kann。

    公开(公告)号:EP0107810A1

    公开(公告)日:1984-05-09

    申请号:EP83109851.2

    申请日:1983-10-03

    IPC分类号: A61B5/14

    摘要: A long indwelling double bore catheter (10) for dilution and sampling of blood on a continuing basis capable of being used for long periods of time. The long indwelling double bore catheter has a small mixing chamber (20) with an opening of a cross-sectional area (34) equal to or less than the combined cross-sectional areas of the double bores, said opening communicating with the body fluid, e.g., blood, to be sampled, and wherein the distance of the mixing chamber from the distal end of the double bores to the end of the catheter is equal to or greater than 2 millimeters. Preferably, the volume of the mixing chamber is between about 3 and about 9 x 10- 5 cubic inches. Preferably, the opening which communicates with the body fluid is a noncircular elongated opening (22) which is equal to or less than twice the combined cross-sectional areas of the double bores.

    摘要翻译: 一种长期留置的双孔导管(10),用于连续地稀释和取样血液,可长期使用。 长的留置双孔导管具有小的混合室(20),其开口的横截面积(34)等于或小于双孔的组合横截面面积,所述开口与体液连通, 例如血液,待采样,并且其中混合室从双孔的远端到导管的端部的距离等于或大于2毫米。 优选地,混合室的体积为约3至约9×10 -5立方英寸。 优选地,与体液连通的开口是非圆形细长开口(22),其等于或小于双孔的组合横截面面积的两倍。

    Method for measuring IgG in a neonatal foal or calf and in colostrum
    42.
    发明公开
    Method for measuring IgG in a neonatal foal or calf and in colostrum 失效
    Verfahren zur Messung von IgG in einem neonatalem Fohlen oder Kalb und im Kolostrum。

    公开(公告)号:EP0106122A2

    公开(公告)日:1984-04-25

    申请号:EP83108843.0

    申请日:1983-09-08

    发明人: Adams, Ernest C.

    IPC分类号: G01N33/546

    CPC分类号: G01N33/54313 G01N33/6854

    摘要: A method is provided for determining the amount of IgG present in a neonatal foal or calf or in the colostrum of a dam or cow. The method involves contacting a body fluid sample with biologically inert latex particles, measuring the amount of agglutination which occurs, and determining the amount of IgG present. The latex particles are diluted to a final concentration of from about 0.65 to 2.0 percent (w/v) at a pH of from about 7.5 to 9.0 with a buffer. The body fluid is diluted to a range of from .01:12 parts to .01:2160 parts, v/v basis, at a pH of from about 7.5 to 9.0.

    摘要翻译: 提供了一种用于确定存在于新生儿驹或小腿中或存在于大坝或母牛初乳中的IgG的量的方法。 该方法包括使体液样品与生物惰性胶乳颗粒接触,测量发生的凝集的量,并确定存在的IgG的量。 用缓冲液将胶乳颗粒在约7.5至9.0的pH下稀释至约0.65-2.0%(w / v)的终浓度。 将体液稀释至0.01:12:1至0.01:21:60,v / v的范围,pH值为约7.5至9.0。

    Ascorbate-resistant broad range glucose test composition, test device and method
    47.
    发明公开
    Ascorbate-resistant broad range glucose test composition, test device and method 失效
    对于用于测试葡萄糖,测试设备和方法的宽范围的合适的抗坏血酸性组合物。

    公开(公告)号:EP0102504A1

    公开(公告)日:1984-03-14

    申请号:EP83107309.3

    申请日:1983-07-26

    发明人: Bauer, Robert

    IPC分类号: C12Q1/54 G01N33/52 G01N33/66

    摘要: A composition, test device and method for detecting the presence and/or determining concentration of glucose in a liquid test sample are disclosed. The composition is capable of determining glucose concentration over a broad range, e.g. 0 to about 5,000 milligrams (mg) of glucose per deciliter (d1) of test sample. Moreover, the composition is resistant to interference from the presence of ascorbate in the sample. The composition comprises glucose oxidase, peroxidase and, as an indicator capable of producing a detectable response in the presence of peroxidase and H 2 0 2 , a mixture of two compounds. One has the structure
    and the other has the structure
    in which R, same of different, is H or lower alkyl, R' is aryl and R" is lower alkyl.

    Test for esterase activity in a liquid sample
    48.
    发明公开
    Test for esterase activity in a liquid sample 失效
    测试液体样品中的酯酶活性。

    公开(公告)号:EP0094554A1

    公开(公告)日:1983-11-23

    申请号:EP83104371.6

    申请日:1983-05-04

    IPC分类号: C12Q1/34

    CPC分类号: C12Q1/44 Y10S435/805

    摘要: A composition, test device and method for determining the presence of leukocytes, esterase and/or esterase activity in a test sample is disclosed. The composition comprises an ester which, when cleaved by esterolytic activity, produces a detectable response such as color formation. In addition the composition comprises the compound 3-quinuclidinol. The device is prepared by incorporating a carrier matrix, such as paper, with the composition. The method comprises contacting a test sample with the device and observing a detectable response.